Healthcare provider profile · identity verified

Michael Sayers, MD

Family Practice · LINCOLN, NE · NPI 1689762874

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	229	49
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	185	18
Atorvastatin Calcium	Atorvastatin Calcium	182	45
Amlodipine Besylate	Amlodipine Besylate	171	39
Omeprazole	Omeprazole	157	34
Meloxicam	Meloxicam	138	37
Alprazolam	Alprazolam	117	21
Hydrochlorothiazide	Hydrochlorothiazide	110	34
Levothyroxine Sodium	Levothyroxine Sodium	109	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	101	22
Duloxetine Hcl	Duloxetine Hcl	98	17
Simvastatin	Simvastatin	98	25
Gabapentin	Gabapentin	95	13
Metformin Hcl	Metformin Hcl	91	20
Celecoxib	Celecoxib	89	19
Montelukast Sodium	Montelukast Sodium	78	12
Nebivolol Hcl	Nebivolol Hcl	75	17
Ozempic	Semaglutide	74	12
Tamsulosin Hcl	Tamsulosin Hcl	68	18
Lisinopril	Lisinopril	65	16
Tramadol Hcl	Tramadol Hcl	65	13
Pregabalin	Pregabalin	64	16
Pantoprazole Sodium	Pantoprazole Sodium	63	22
Rosuvastatin Calcium	Rosuvastatin Calcium	62	17
Tizanidine Hcl	Tizanidine Hcl	60	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	15
Metoprolol Succinate	Metoprolol Succinate	59	17
Prednisone	Prednisone	56	30
Zolpidem Tartrate	Zolpidem Tartrate	56	13
Donepezil Hcl	Donepezil Hcl	49	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	48	16
Ventolin Hfa	Albuterol Sulfate	47	suppressed
Carvedilol	Carvedilol	46	11
Synthroid	Levothyroxine Sodium	44	suppressed
Symbicort	Budesonide/Formoterol Fumarate	43	suppressed
Metformin Hcl Er	Metformin Hcl	40	11
Bupropion Xl	Bupropion Hcl	39	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	14
Furosemide	Furosemide	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	11
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Potassium Chloride	Potassium Chloride	34	suppressed
Oxycontin	Oxycodone Hcl	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Mounjaro	Tirzepatide	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Fentanyl	Fentanyl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	24
Eszopiclone	Eszopiclone	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	27	12
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Famotidine	Famotidine	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Jardiance	Empagliflozin	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	22	suppressed
Glimepiride	Glimepiride	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Eliquis	Apixaban	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Hydrocodone-Ibuprofen	Hydrocodone/Ibuprofen	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Repatha Sureclick	Evolocumab	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Allopurinol	Allopurinol	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Nabumetone	Nabumetone	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Diazepam	Diazepam	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Trazodone Hcl	Trazodone Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Risperidone	Risperidone	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Livalo	Pitavastatin Calcium	15	suppressed
Naproxen	Naproxen	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Roflumilast	Roflumilast	15	suppressed
Sertraline Hcl	Sertraline Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Estradiol	Estradiol	14	suppressed
Temazepam	Temazepam	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Alprazolam Xr	Alprazolam	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Gemtesa	Vibegron	13	suppressed
Jentadueto	Linagliptin/Metformin Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Atenolol	Atenolol	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error